Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Asset Writedowns and Impairment of $36.45 million for the quarter ended Jun 30, 2026, up 90.8% from $19.1 million a year earlier and up 28.9% from the prior quarter.
Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Asset Writedowns and Impairment at Dr Reddys Laboratories was $75.37 million, up 93.5% year-over-year; for the year ended Mar 31, 2026, it was $80 million, up 31.1% from the prior year.
- Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of -7.3% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Asset Writedowns and Impairment was $61 million in the year ended Mar 31, 2025 (+41.9%), $43 million in the year ended Mar 31, 2024 (-27.1%), $59 million in the year ended Mar 31, 2023 (-41.0%) and $100 million in the year ended Mar 31, 2022 (-14.5%).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Asset Writedowns and Impairment since the quarter ended Mar 31, 2022.
- On a year-over-year basis, Asset Writedowns and Impairment increased in three of the last four quarters, with growth averaging 75.1%.
- The strongest year-over-year quarter for Asset Writedowns and Impairment in the past five years was the quarter ended Mar 31, 2022, with growth of 297.1%; the weakest was the quarter ended Sep 30, 2021, with a decline of 98.8%.
- According to Business Quant data, Asset Writedowns and Impairment for the three prior quarters was $28.29 million (quarter ended Mar 31, 2026), $3.04 million (quarter ended Dec 31, 2025) and $7.59 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.45 Mn |
| Mar 31, 2026 | 28.29 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 19.10 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | -47,374.77 |
| Sep 30, 2024 | 11.03 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Mar 31, 2024 | -2.08 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 665,334.27 |
| Jun 30, 2023 | 1.00 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 15.94 Mn |
| Mar 31, 2022 | 99.94 Mn |
| Dec 31, 2021 | 99.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 11.00 Mn |
Dr Reddys Laboratories Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();